Prescribing clarity: mapping the link between antihypertensives and breast cancer
Introduction: The relationship between antihypertensive medication and breast cancer outcomes remains a subject of growing interest in clinical research. This systematic review aims to evaluate the potential associations between antihypertensives and breast cancer outcomes, providing a detailed synt...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zabansaraye Parsian Novin Mehr Institute
2024-12-01
|
| Series: | Journal of Current Oncology and Medical Sciences |
| Subjects: | |
| Online Access: | https://submission.journalofcoms.com/index.php/JCOMS/article/view/250 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841527802428391424 |
|---|---|
| author | Shadman Newaz Moontasir Ahmed Jannat Ara Tina Talukder Nasif Shahriar Abdulla Bin Hridoy Supritom Sarker Mohammad Zakaria Al-Aziz Md. Robed Amin |
| author_facet | Shadman Newaz Moontasir Ahmed Jannat Ara Tina Talukder Nasif Shahriar Abdulla Bin Hridoy Supritom Sarker Mohammad Zakaria Al-Aziz Md. Robed Amin |
| author_sort | Shadman Newaz |
| collection | DOAJ |
| description | Introduction: The relationship between antihypertensive medication and breast cancer outcomes remains a subject of growing interest in clinical research. This systematic review aims to evaluate the potential associations between antihypertensives and breast cancer outcomes, providing a detailed synthesis of current evidence and identifying areas for future research.
Methods: We conducted a systematic review of studies published between January 2014 and January 2024, in accordance with a registered protocol on the Open Science Framework. Multiple databases were searched for English-language studies of various designs, including clinical trials, cohort studies, and observational studies. A total of 51 studies were selected from 1,591 records after a rigorous screening process. The review focused on summarizing the evidence without formal quality appraisal, adhering to the scope of this review.
Results: Our review identified potential links between certain antihypertensive classes, such as ACE inhibitors and calcium channel blockers, and breast cancer outcomes. The findings indicate that specific antihypertensive medications may influence breast cancer-specific mortality, recurrence rates, and overall survival. The role of the Renin-Angiotensin System and genetic predispositions emerged as important factors in these associations. However, the review also highlights substantial evidence gaps, particularly regarding long-term outcomes and the interaction between antihypertensive treatment and breast cancer biology.
Conclusion: This systematic review contributes to a better understanding of the complex relationship between antihypertensive medications and breast cancer outcomes. Key findings suggest that healthcare providers should consider the potential implications of specific antihypertensive drugs in patients with breast cancer. Further large-scale randomized controlled trials with extended follow-up are recommended to clarify these associations and inform clinical guidelines. Our findings underscore the importance of personalized treatment approaches and adherence to cardiovascular regimens in this patient population. |
| format | Article |
| id | doaj-art-16ec190790a440a78d33751667c62b10 |
| institution | Kabale University |
| issn | 2783-3127 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Zabansaraye Parsian Novin Mehr Institute |
| record_format | Article |
| series | Journal of Current Oncology and Medical Sciences |
| spelling | doaj-art-16ec190790a440a78d33751667c62b102025-01-15T06:44:17ZengZabansaraye Parsian Novin Mehr InstituteJournal of Current Oncology and Medical Sciences2783-31272024-12-0144977989Prescribing clarity: mapping the link between antihypertensives and breast cancerShadman Newaz 0Moontasir Ahmed1Jannat Ara Tina2Talukder Nasif Shahriar3Abdulla Bin Hridoy4Supritom Sarker5Mohammad Zakaria Al-Aziz6Md. Robed Amin7Sheikh Hasina Medical College, Tangail, BangladeshSheikh Hasina Medical College, Tangail, BangladeshSheikh Hasina Medical College, Tangail, BangladeshSheikh Hasina Medical College, Tangail, BangladeshSheikh Hasina Medical College, Tangail, BangladeshSheikh Hasina Medical College, Tangail, BangladeshSheikh Hasina Medical College, Tangail, BangladeshNon-communicable Disease, DGHS, Dhaka, BangladeshIntroduction: The relationship between antihypertensive medication and breast cancer outcomes remains a subject of growing interest in clinical research. This systematic review aims to evaluate the potential associations between antihypertensives and breast cancer outcomes, providing a detailed synthesis of current evidence and identifying areas for future research. Methods: We conducted a systematic review of studies published between January 2014 and January 2024, in accordance with a registered protocol on the Open Science Framework. Multiple databases were searched for English-language studies of various designs, including clinical trials, cohort studies, and observational studies. A total of 51 studies were selected from 1,591 records after a rigorous screening process. The review focused on summarizing the evidence without formal quality appraisal, adhering to the scope of this review. Results: Our review identified potential links between certain antihypertensive classes, such as ACE inhibitors and calcium channel blockers, and breast cancer outcomes. The findings indicate that specific antihypertensive medications may influence breast cancer-specific mortality, recurrence rates, and overall survival. The role of the Renin-Angiotensin System and genetic predispositions emerged as important factors in these associations. However, the review also highlights substantial evidence gaps, particularly regarding long-term outcomes and the interaction between antihypertensive treatment and breast cancer biology. Conclusion: This systematic review contributes to a better understanding of the complex relationship between antihypertensive medications and breast cancer outcomes. Key findings suggest that healthcare providers should consider the potential implications of specific antihypertensive drugs in patients with breast cancer. Further large-scale randomized controlled trials with extended follow-up are recommended to clarify these associations and inform clinical guidelines. Our findings underscore the importance of personalized treatment approaches and adherence to cardiovascular regimens in this patient population.https://submission.journalofcoms.com/index.php/JCOMS/article/view/250antihypertensive drugsbreast cancer riskhypertensionmedication associations |
| spellingShingle | Shadman Newaz Moontasir Ahmed Jannat Ara Tina Talukder Nasif Shahriar Abdulla Bin Hridoy Supritom Sarker Mohammad Zakaria Al-Aziz Md. Robed Amin Prescribing clarity: mapping the link between antihypertensives and breast cancer Journal of Current Oncology and Medical Sciences antihypertensive drugs breast cancer risk hypertension medication associations |
| title | Prescribing clarity: mapping the link between antihypertensives and breast cancer |
| title_full | Prescribing clarity: mapping the link between antihypertensives and breast cancer |
| title_fullStr | Prescribing clarity: mapping the link between antihypertensives and breast cancer |
| title_full_unstemmed | Prescribing clarity: mapping the link between antihypertensives and breast cancer |
| title_short | Prescribing clarity: mapping the link between antihypertensives and breast cancer |
| title_sort | prescribing clarity mapping the link between antihypertensives and breast cancer |
| topic | antihypertensive drugs breast cancer risk hypertension medication associations |
| url | https://submission.journalofcoms.com/index.php/JCOMS/article/view/250 |
| work_keys_str_mv | AT shadmannewaz prescribingclaritymappingthelinkbetweenantihypertensivesandbreastcancer AT moontasirahmed prescribingclaritymappingthelinkbetweenantihypertensivesandbreastcancer AT jannataratina prescribingclaritymappingthelinkbetweenantihypertensivesandbreastcancer AT talukdernasifshahriar prescribingclaritymappingthelinkbetweenantihypertensivesandbreastcancer AT abdullabinhridoy prescribingclaritymappingthelinkbetweenantihypertensivesandbreastcancer AT supritomsarker prescribingclaritymappingthelinkbetweenantihypertensivesandbreastcancer AT mohammadzakariaalaziz prescribingclaritymappingthelinkbetweenantihypertensivesandbreastcancer AT mdrobedamin prescribingclaritymappingthelinkbetweenantihypertensivesandbreastcancer |